Asymptomatic Transmissibility Calls for Implementing a Zero-COVID Strategy to End the Current Global Crisis

  title={Asymptomatic Transmissibility Calls for Implementing a Zero-COVID Strategy to End the Current Global Crisis},
  author={Chaobao Zhang and Hongzhi Wang and Zilu Wen and Mingjun Gu and Lianyong Liu and Xiangqi Li},
  journal={Frontiers in Cellular and Infection Microbiology},
The coronavirus disease 2019 (COVID-19) pandemic has led to unprecedented global challenges. A zero-COVID strategy is needed to end the crisis, but there is a lack of biological evidence. In the present study, we collected available data on SARS, MERS, and COVID-19 to perform a comprehensive comparative analysis and visualization. The study results revealed that the fatality rate of COVID-19 is low, whereas its death toll is high compared to SARS and MERS. Moreover, COVID-19 had a higher… 

Figures from this paper


Prudent public health intervention strategies to control the coronavirus disease 2019 transmission in India: A mathematical model-based approach
Port-of-entry-based entry screening of travellers with suggestive clinical features and from COVID-19-affected countries, would achieve modest delays in the introduction of the virus into the community, but acting alone would be insufficient to delay the outbreak by weeks or longer.
Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19
It is found that most cases missed by screening are fundamentally undetectable, because they have not yet developed symptoms and are unaware they were exposed, which underscores the need for measures to limit transmission by individuals who become ill after being missed by a screening program.
Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)
It is estimated that 86% of all infections were undocumented before the 23 January 2020 travel restrictions, which explains the rapid geographic spread of SARS-CoV-2 and indicates that containment of this virus will be particularly challenging.
Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model
Comparisons of three human coronaviruses in cynomolgus macaques show that SARS-CoV-2 causes COVID-19–like disease in macaques and provides a new model to test preventive and therapeutic strategies.
The dichotomous and incomplete adaptive immunity in COVID-19 patients with different disease severity
The protective immunity in asymptomatic patients is uncovered and the strikingly dichotomous and incomplete humoral and cellular immune responses in COVID-19 patients with different disease severity are revealed, providing important insights into rational design of effective CO VID-19 vaccines.
Virological assessment of hospitalized patients with COVID-2019
Detailed virological analysis of nine cases of coronavirus disease 2019 (COVID-19) provides proof of active replication of the SARS-CoV-2 virus in tissues of the upper respiratory tract.
Cluster of coronavirus disease 2019 (Covid-19) in the French Alps, 2020
  • K. Danis, O. Epaulard, A. Mounayar
  • Medicine
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2020
The occurrence in this cluster of one asymptomatic case with similar viral load as a symptomatic patient, suggests transmission potential of asymPTomatic individuals and underscores the need for close monitoring of the clinical evolution of suspect Covid-19 cases.